1261493-38-2 Usage
Uses
Used in Pharmaceutical Industry:
4-Chloro-6-Methoxynicotinonitrile is utilized as a key intermediate in the production of pharmaceuticals, contributing to the development of various medications. Its role in the synthesis of biologically active compounds makes it instrumental in creating new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, 4-Chloro-6-Methoxynicotinonitrile is employed as a precursor in the synthesis of agrochemicals, which are essential for crop protection and enhancement of agricultural productivity. Its involvement in the creation of these chemicals underscores its importance in supporting food security and sustainable agriculture.
Used in Organic Synthesis:
4-Chloro-6-Methoxynicotinonitrile is used as a building block in organic synthesis for the preparation of a wide range of chemical compounds. Its unique properties allow for the construction of complex molecules that can be applied across various industries, including the development of new materials and the advancement of chemical research.
Used in Research and Development:
4-Chloro-6-Methoxynicotinonitrile is also used as a research tool in academic and industrial laboratories. It aids scientists in understanding the fundamental principles of chemical reactions and serves as a platform for the discovery of new chemical entities and processes. Its application in research and development is crucial for driving innovation and expanding the frontiers of chemical knowledge.
Check Digit Verification of cas no
The CAS Registry Mumber 1261493-38-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,1,4,9 and 3 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1261493-38:
(9*1)+(8*2)+(7*6)+(6*1)+(5*4)+(4*9)+(3*3)+(2*3)+(1*8)=152
152 % 10 = 2
So 1261493-38-2 is a valid CAS Registry Number.
1261493-38-2Relevant academic research and scientific papers
The Rational Design of Selective Benzoxazepin Inhibitors of the α-Isoform of Phosphoinositide 3-Kinase Culminating in the Identification of (S)-2-((2-(1-Isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)oxy)propanamide (
Heffron, Timothy P.,Heald, Robert A.,Ndubaku, Chudi,Wei, BinQing,Augistin, Martin,Do, Steven,Edgar, Kyle,Eigenbrot, Charles,Friedman, Lori,Gancia, Emanuela,Jackson, Philip S.,Jones, Graham,Kolesnikov, Aleksander,Lee, Leslie B.,Lesnick, John D.,Lewis, Cristina,McLean, Neville,M?rtl, Mario,Nonomiya, Jim,Pang, Jodie,Price, Steve,Prior, Wei Wei,Salphati, Laurent,Sideris, Steve,Staben, Steven T.,Steinbacher, Stefan,Tsui, Vickie,Wallin, Jeffrey,Sampath, Deepak,Olivero, Alan G.
, p. 985 - 1002 (2016/02/23)
Inhibitors of the class I phosphoinositide 3-kinase (PI3K) isoform PI3Kα have received substantial attention for their potential use in cancer therapy. Despite the particular attraction of targeting PI3Kα, achieving selectivity for the inhibition of this
BENZOXAZEPIN COMPOUNDS SELECTIVE FOR PI3K P110 DELTA AND METHODS OF USE
-
, (2012/10/08)
Benzoxazepin Formula I compounds, including stereoisomers, geometric isomers, tautomers, metabolites and pharmaceutically acceptable salts thereof, are useful for inhibiting the delta isoform of PI3K, and for treating disorders mediated by lipid kinases such as inflammation, immunological disorders, and cancer. Methods of using compounds of Formula I for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.
